Market Tracker

05/21 4:41pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

35.68
Delayed Data
As of 4:00pm ET
 +0.28 / +0.79%
Today’s Change
19.75
Today|||52-Week Range
41.57
+3.89%
Year-to-Date

Today’s Trading

Previous close35.40
Today’s open35.53
Day’s range35.28 - 35.95
Volume467,656
Average volume (3 months)723,665
Market cap$2.4B
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)+13.97%
Earnings growth (next 5 years)+12.06%
Revenue growth (last year)+2.33%
P/E ratio18.5
Price/Sales2.30
Price/Book3.03

Competitors

----
NEOGNeogen Corp+0.51+0.68%
IMMUImmunomedics Inc+0.21+1.00%
QDELQuidel Corp-0.49-0.77%
Data as of 4:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)$0.31
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts